ExodusPoint Capital Management’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.28M	Buy	+106,147	New	+$3.97M	0.04%	490
2023 Q4	–	Sell	-24,832	Closed	-$677K	–	1552
2023 Q3	$677K	Sell	24,832 -80,278	-76%	-$2.32M	0.01%	1129
2023 Q2	$2.34M	Buy	105,110 +48,701	+86%	+$1.12M	0.03%	747
2023 Q1	$1.22M	Buy	56,409 +14,755	+35%	+$323K	0.01%	1072
2022 Q4	$846K	Buy	+41,654	New	+$1.04M	0.01%	1006
2022 Q3	–	Sell	-19,210	Closed	-$457K	–	1933
2022 Q2	$457K	Sell	19,210 -68,544	-78%	-$1.49M	0.01%	1400
2022 Q1	$1.98M	Buy	87,754 +10,727	+14%	+$228K	0.03%	787
2021 Q4	$1.52M	Buy	+77,027	New	+$1.56M	0.02%	870
2021 Q1	–	Sell	-16,053	Closed	-$420K	–	2173
2020 Q4	$420K	Sell	16,053 -27,537	-63%	-$580K	0.01%	1352
2020 Q3	$759K	Buy	+43,590	New	+$695K	0.02%	800
2020 Q1	–	Sell	-37,139	Closed	-$449K	–	1154
2019 Q4	$449K	Buy	37,139 +15,074	+68%	+$210K	0.01%	921
2019 Q3	$312K	Buy	+22,065	New	+$271K	0.01%	856